Keystone Financial Group (Kentucky)’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$415K Buy
5,307
+1,240
+30% +$100K 0.02% 360
2026
Q1
$352K Buy
4,067
+237
+6% +$22.7K 0.02% 361
2025
Q4
$368K Sell
3,830
-78
-2% -$7.58K 0.03% 309
2025
Q3
$372K Sell
3,908
-280
-7% -$25.7K 0.03% 285
2025
Q2
$365K Buy
4,188
+948
+29% +$80.4K 0.03% 276
2025
Q1
$291K Buy
3,240
+711
+28% +$63.6K 0.03% 300
2024
Q4
$202K Buy
2,529
+70
+3% +$6.06K 0.02% 372
2024
Q3
$221K Sell
2,459
-285
-10% -$24K 0.03% 338
2024
Q2
$216K Buy
2,744
+270
+11% +$22.1K 0.08% 151
2024
Q1
$216K Buy
+2,474
New +$211K 0.03% 318
2020
Q2
– Sell
-2,616
Closed -$236K – 232
2020
Q1
$236K Buy
2,616
+46
+2% +$4.89K 0.08% 172
2019
Q4
$292K Hold
2,570
– – 0.08% 183
2019
Q3
$279K Sell
2,570
-5
-0.2% -$522 0.09% 181
2019
Q2
$251K Hold
2,575
– – 0.08% 189
2019
Q1
$235K Buy
+2,575
New +$230K 0.08% 186

Other funds holding MDT

Keystone Financial Group (Kentucky)'s MDT Position: Q2 2026 in Review

Keystone Financial Group (Kentucky) increased its Medtronic (MDT) stake by 30% in Q2 2026, buying an estimated $100K and bringing the position to 5,307 shares worth $415K. The position accounts for 0.02% of the portfolio, ranked #360.

Keystone Financial Group (Kentucky) first reported a position in MDT in Q1 2019 and has held it in 15 quarters since. 2,146 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Keystone Financial Group (Kentucky) held 5,307 shares of Medtronic worth $415K as of Q2 2026.
  • Keystone Financial Group (Kentucky) bought 1,240 Medtronic shares in Q2 2026, an estimated $100K.
  • Medtronic made up 0.02% of Keystone Financial Group (Kentucky)'s portfolio in Q2 2026, its #360 holding.
  • Keystone Financial Group (Kentucky) first reported a position in Medtronic in Q1 2019 and has held it in 15 quarters since.
  • 2,146 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Keystone Financial Group (Kentucky)'s 13F filing for Q2 2026, filed 29 Jul 2026.